Literature DB >> 17048061

Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma.

Masakazu Yamamoto, Shun-ichi Ariizumi.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17048061     DOI： 10.1007/s00535-006-1901-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  19 in total

1.  Recurrence after surgical resection of intrahepatic cholangiocarcinoma.

Authors:  M Yamamoto; K Takasaki; T Otsubo; H Katsuragawa; S Katagiri
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

2.  The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

Authors:  A H Patel; D M Harnois; G G Klee; N F LaRusso; G J Gores
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

3.  Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population.

Authors:  E M Vestergaard; H O Hein; H Meyer; N Grunnet; J Jørgensen; H Wolf; T F Orntoft
Journal:  Clin Chem       Date:  1999-01       Impact factor: 8.327

4.  A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables.

Authors:  T Okabayashi; J Yamamoto; T Kosuge; K Shimada; S Yamasaki; T Takayama; M Makuuchi
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

5.  Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma.

Authors:  S Thongprasert; S Napapan; C Charoentum; S Moonprakan
Journal:  Ann Oncol       Date:  2005-02       Impact factor: 32.976

6.  Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.

Authors:  Jennifer J Knox; David Hedley; Amit Oza; Ron Feld; Lillian L Siu; Eric Chen; Mahsan Nematollahi; Gregory R Pond; Jessica Zhang; Malcolm J Moore
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

7.  Intrahepatic cholangiocarcinoma with lymph node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case.

Authors:  Ryota Higuchi; Masakazu Yamamoto; Takashi Hatori; Koichi Shimizu; Kenichirou Imai; Ken Takasaki
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

8.  Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period.

Authors:  Hauke Lang; Georgios C Sotiropoulos; Nils R Frühauf; Marco Dömland; Andreas Paul; Eva-Maria Kind; Massimo Malagó; Christoph E Broelsch
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

9.  Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience.

Authors:  Peter Ghali; Paul J Marotta; Eric M Yoshida; Vincent G Bain; Denis Marleau; Kevork Peltekian; Peter Metrakos; Marc Deschênes
Journal:  Liver Transpl       Date:  2005-11       Impact factor: 5.799

10.  Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma.

Authors:  Ricardo Robles; Joan Figueras; Victor S Turrión; Carlos Margarit; Angel Moya; Evaristo Varo; Javier Calleja; Andres Valdivieso; Juan Carlos G Valdecasas; Pedro López; Manuel Gómez; Emilio de Vicente; Carmelo Loinaz; Julio Santoyo; Manuel Fleitas; Angel Bernardos; Laura Lladó; Pablo Ramírez; F S Bueno; Eduardo Jaurrieta; Pascual Parrilla
Journal:  Ann Surg       Date:  2004-02       Impact factor: 12.969
View more
  2 in total

1.  CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.

Authors:  Mitsuo Shimada; Koji Sugimoto; Shuichi Iwahashi; Tohru Utsunomiya; Yuji Morine; Satoru Imura; Tetsuya Ikemoto
Journal:  J Gastroenterol       Date:  2010-04-09       Impact factor: 7.527

2.  Patterns of Recurrence after Resection of Mass-Forming Typezzm321990Intrahepatic Cholangiocarcinomas

Authors:  Vor Luvira; Chalerm Eurboonyanun; Vajarabhongsa Bhudhisawasdi; Ake Pugkhem; Chawalit Pairojkul; Varisara Luvira; Egapong Sathitkarnmanee; Kulyada Somsap; Supot Kamsa-ard
Journal:  Asian Pac J Cancer Prev       Date:  2016-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.